Agile Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Agile Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Amount of $3.02 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-15
- Agile Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was $333.00.
- Agile Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $0.00.
- Agile Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $3.02M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2014-12-31 | $333.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $333.00 derived: sum of 2 quarters · filed 2017-03-15 | $3.02M 10-K · filed 2017-03-15 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.02M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $3.02M 10-Q · filed 2015-08-13 |